The Regulatory Effects Of Thyroid Hormone On The Activity Of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase

References

• Pazos F., Alvarez J. J., Rubies-Prat J., Varela C., Lasuncion M. A. Long-term thyroid replacement therapy and levels of lipoprotein(a) and other lipoproteins. J Clin Endocrinol Metab 1995; 80: 562–566
   PubMed Web of Science ®Google Scholar
• Day R., Gebhard R. L., Schwartz H. L., Strait K. A., Duane W. C., Stone B. G., Oppenheimer J. H. Time course of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and messenger ribonucleic acid, biliary lipid secretion, and hepatic cholesterol content in methimazole-treated hypothyroid and hypophysectomized rats after triiodothyronine administration: possible linkage of cholesterol synthesis to biliary secretion. Endocrinology 1989; 125: 459–468
   PubMed Web of Science ®Google Scholar
• Ness G. C., Lopez D. Transcriptional regulation of rat hepatic low-density lipoprotein receptor and cholesterol 7μ-hydroxylase by thyroid hormone. Arch Biochem Biophys 1995; 323: 404–408
   PubMed Web of Science ®Google Scholar
• Simonet W. S., Ness G. C. Transcriptional and posttranscriptional regulation of rat hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase by thyroid hormones. J Biol Chem 1988; 263: 12448–12453
   PubMed Web of Science ®Google Scholar
• Goldstein J. L., Brown M. S. Regulation of the mevalonate pathway. Nature 1990; 343: 425–430
   PubMed Web of Science ®Google Scholar
• Choi J. W., Jung S. E. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells. J Pharm Exp Ther 1999; 289: 572–579
   PubMed Web of Science ®Google Scholar
• Zhang F. L., Casey P. J. Protein prenylation: Molecular mechanisms and functional consequences. Annu Rev Biochem 1996; 65: 241–269
   PubMed Web of Science ®Google Scholar
• Brown M. S., Goldstein J. L. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997; 89: 331–340
   PubMed Web of Science ®Google Scholar
• Choi J. W., Lundquist E. N., Peffley D. M. Inhibition of protein synthesis in baby-hamster kidney cells blocks oxysterol-mediated suppression of 3-hydroxy-3-methylglutaryl-CoA reductase mRNA at a post-transcriptional level. Biochem J 1993; 296: 859–866
   PubMed Web of Science ®Google Scholar
• Choi J. W., Peffley D. M. 3'-untranslated sequences mediate posttranscriptional regulation of 3-hydroxy-3-methylglutaryl-CoA reductase mRNA by 25-hydroxycholesterol. Biochem J 1995; 307: 233–238
   PubMed Web of Science ®Google Scholar
• Chambers C. M., Ness G. C. Dietary cholesterol regulates hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in rats primarily at the level of translation. Arch Biochem Biophys 1998; 354: 317–322
   PubMed Web of Science ®Google Scholar
• Brown M. S., Goldstein J. L., Dietschy J. M. Active and inactive forms of 3-hydroxy-3-methylglutaryl coenzyme A reductase in the liver of the rat. Comparison with the rate of cholesterol synthesis in different physiological states. J Biol Chem 1979; 254: 5144–5149
   PubMed Web of Science ®Google Scholar
• Miller S. J., Parker R. A., Gibson D. M. Phosphorylation and degradation of HMG-CoA reductase. Adv Enzyme Regul 1989; 28: 65–77
   PubMedGoogle Scholar
• Ichikawa K., Hashizurne K. Thyroid hormone action in the cell. Endocr Rev 1995; 42: 131–140
   Google Scholar
• Kem P. A., Ranganathan G., Yukht A., Ong JM., Davis RC. Translational regulation of lipoprotein lipase by thyroid hormone is via a cytoplasmic repressor that interacts with the 3' untranslated region. J Lipid Res 1996; 37: 2332–2340
   PubMed Web of Science ®Google Scholar
• Leedman P. J., Stein A. R., Chin W. W. Regulated specific protein binding to a conserved region of the 3'-untranslated region of thyrotropin μ-subunit mRNA. Mol Endocrinol 1995; 9: 375–387
   PubMedGoogle Scholar
• Rodriguez-Pena A., Ibarrola N., Iniguez M. A., Munoz A., Bernal J. Neonatal hypothyroidism affects the timely expression of myelin-associated glycoprotein in the rat brain. J Clin Invest 1993; 91: 812–818
   PubMed Web of Science ®Google Scholar
• Vandenbrouck Y., Janvier B., Loriette C., Bereziat G., Mangeney-Andreani M. Thyroid hormone modulates apolipoprotein-Al gene expression at the post-transcriptional level in HepG2 cells. Eur J Biochem 1995; 231: 126–132
   PubMedGoogle Scholar
• Burmeister L. A., Pachucki J., St. Germain DD. Thyroid hormones inhibit type 2 iodothyronine deiodinase in the rat cerebral cortex by both pre- and posttranslational mechanisms. Endocrinology 1997; 138: 5231–5237
   PubMed Web of Science ®Google Scholar
• Lin H. Y., Thacore H. R., Davis F. B., Davis P. J. Thyroid hormone analogues potentiate the antiviral action of interferon-gamma by two mechanisms. J Cell Physiol 1996; 167: 269–276
   PubMed Web of Science ®Google Scholar
• Samuels H. H., Forman B. M., Horowitz Z. D., Ye Z. S. Regulation of gene expression by thyroid hormone. J Clin Invest 1988; 81: 957–961
   PubMed Web of Science ®Google Scholar
• Kita T., Brown M. S., Goldstein J. L. Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase. J Clin Invest 1980; 66: 1094–1100
   PubMed Web of Science ®Google Scholar
• Goldstein J. L., Basu S. K., Brown M. S. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol 1983; 98: 241–260
   PubMed Web of Science ®Google Scholar
• Kaneko I., Hazama-Shimada Y., Endo A. Inhibitory effects on lipid metabolism in cultured cells of ML-23613, a potent inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase. Eur J Biochem 1978; 87: 313–321
   PubMedGoogle Scholar
• Shapiro D. J., Nordstrom J. L., Mitschelen J. J., Rodwell V. W., Schinike K. T. Microassay for 3-hydroxy-3-methylglutaryl-CoA reductase in rat liver and in L-cell fibroblasts. Biochim Biophys Acta 1974; 370: 369–377
   PubMed Web of Science ®Google Scholar
• Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Ness G. C., Lopez D., Chambers C. M., Newsome W. P., Cornelius P., Long C. A., Harwood H. J. Effects of L-triiodothyronine and the thyromimetic L-94901 on serum lipoprotein levels and hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and Apo A-I gene expression. Biochem Pharmacol 1998; 56: 121–129
   PubMed Web of Science ®Google Scholar
• Balasubramaniam S., Szanto A., Roach P. D. Circadian rhythm in hepatic low-density-lipoprotein (LDL)-receptor expression and plasma LDL levels. Biochem J 1994; 298: 39–43
   PubMed Web of Science ®Google Scholar
• Ness G. C., Chambers C. M. The diurnal variation of hepatic HMG-CoA reductase activity is due to changes in the level of immunoreactive protein. Arch Biochem Biophys 1996; 327: 41–44
   PubMed Web of Science ®Google Scholar
• Sakai J., Nohturfft A., Goldstein J. L., Brown M. S. Cleavage of sterol regulatory element-binding proteins (SREBPs) at site-1 requires interaction with SREBP cleavage-activating protein. J Biol Chem 1998; 273: 5785–5793
   PubMed Web of Science ®Google Scholar
• Leedman P. J., Stein A. R., Chin W. W., Rogers J. T. Thyroid hormone modulates the interaction between iron regulatory proteins and the ferritin mRNA iron-responsive element. J Biol Chem 1996; 271: 12017–12023
   PubMed Web of Science ®Google Scholar
• Staton J. M., Leedman P. J. Posttranscriptional regulation of thyrotropin beta-subunit messenger ribonucleic acid by thyroid hormone in murine thyrotrope tumor cells: a conserved mechanism across species. Endocrinology 1998; 139: 1093–1100
   PubMed Web of Science ®Google Scholar